Therefore, DHTS inhibits the growth of the drug-resistant HCT116/OXA strain and HCT116/OXA xenograft tumor through multiple aspects, including promoting apoptosis, blocking cell cycle in S and G2/M phases, inducing DNA damage, and reducing the expression of drug-resistant proteins MRP1 and P-gp (Figure 9). Here, PGP is linked to neoplasm.